Stay updated on Modified RNA Influenza Vaccine Safety Clinical Trial
Sign up to get notified when there's something new on the Modified RNA Influenza Vaccine Safety Clinical Trial page.

Latest updates to the Modified RNA Influenza Vaccine Safety Clinical Trial page
- Check3 days agoChange DetectedAdded a government funding notice about potential data currency and operating status and updated the page to revision v3.4.1, replacing the previous v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoChange DetectedThe glossary toggle is now visible, the page shows the Last Update Submitted that Met QC Criteria date, and the No FEAR Act Data label appears; the revision tag has been updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a new revision tag 'Revision: v3.3.4' replacing 'Revision: v3.3.3'. This appears to be a minor version update that does not change the study details or user actions.SummaryDifference0.0%

- Check46 days agoChange DetectedLocations section updated to list participating states (Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Iowa, Kansas, Maryland, Michigan, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Virginia) and the page revision now shows Revision: v3.3.3.SummaryDifference1.0%

- Check68 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedThese changes update PubMed data source notes and revision identifiers on the study page, which are minor metadata updates and do not affect the study details; to avoid alerts for small changes, set an alert condition below.SummaryDifference0.0%

Stay in the know with updates to Modified RNA Influenza Vaccine Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modified RNA Influenza Vaccine Safety Clinical Trial page.